X-142203707-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016249.4(MAGEC2):c.281G>T(p.Gly94Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,206,652 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016249.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEC2 | NM_016249.4 | c.281G>T | p.Gly94Val | missense_variant | 3/3 | ENST00000247452.4 | NP_057333.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEC2 | ENST00000247452.4 | c.281G>T | p.Gly94Val | missense_variant | 3/3 | 1 | NM_016249.4 | ENSP00000354660 | P1 | |
ENST00000664519.1 | n.300+7923C>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.00000916 AC: 1AN: 109138Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 31676
GnomAD3 exomes AF: 0.00000551 AC: 1AN: 181596Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66722
GnomAD4 exome AF: 0.0000118 AC: 13AN: 1097464Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 5AN XY: 363270
GnomAD4 genome AF: 0.00000916 AC: 1AN: 109188Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 31738
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.281G>T (p.G94V) alteration is located in exon 3 (coding exon 1) of the MAGEC2 gene. This alteration results from a G to T substitution at nucleotide position 281, causing the glycine (G) at amino acid position 94 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at